Nutex Health Inc.
NUTX
$122.90
$4.443.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 624.28M | 479.95M | 292.00M | 275.93M | 258.77M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 624.28M | 479.95M | 292.00M | 275.93M | 258.77M |
| Cost of Revenue | 299.96M | 264.72M | 205.78M | 204.78M | 200.90M |
| Gross Profit | 324.32M | 215.23M | 86.22M | 71.15M | 57.87M |
| SG&A Expenses | 95.98M | 58.56M | 40.26M | 36.28M | 35.70M |
| Depreciation & Amortization | 19.88M | 18.97M | 18.37M | 18.15M | 17.78M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 415.82M | 342.24M | 264.42M | 259.21M | 254.38M |
| Operating Income | 208.46M | 137.71M | 27.58M | 16.72M | 4.39M |
| Income Before Tax | 172.67M | 109.75M | -29.54M | -31.82M | -40.81M |
| Income Tax Expenses | 32.63M | 14.48M | 2.87M | -2.06M | -3.77M |
| Earnings from Continuing Operations | 140.04 | 95.27 | -32.41 | -29.77 | -37.04 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -72.86M | -43.09M | -8.73M | -8.12M | -3.96M |
| Net Income | 67.18M | 52.18M | -41.13M | -37.89M | -41.00M |
| EBIT | 208.46M | 137.71M | 27.58M | 16.72M | 4.39M |
| EBITDA | 227.28M | 156.68M | 46.26M | 35.22M | 22.43M |
| EPS Basic | 12.69 | 9.96 | -9.37 | -8.90 | -9.62 |
| Normalized Basic EPS | 7.49 | 5.76 | -0.91 | -1.24 | -2.44 |
| EPS Diluted | 11.88 | 9.24 | -9.38 | -8.91 | -9.63 |
| Normalized Diluted EPS | 7.05 | 5.42 | -0.91 | -1.24 | -2.44 |
| Average Basic Shares Outstanding | 20.80M | 20.13M | 19.13M | 18.47M | 17.88M |
| Average Diluted Shares Outstanding | 21.47M | 20.47M | 19.13M | 18.47M | 17.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 10.96% | 0.92% | -1.17% | -1.27% | -3.98% |